Experts have informed that the Indian pharma has moved from volume-led generics to value plus innovation-led growth through strategic mergers and acquisitions (M&As) over the past one year. The ...

Rift deepens in Assam pharma trade as ADDA refuses to join nationwide pharmacy bandh: Peethaambaran Kunnathoor, Chennai Saturday, May 9, 2026, 08:00 Hrs [IST] The pharmaceutical t ...

Pharmacy institutes stress on PM Internship Scheme for hands-on training and better employability: Nandita Vijayasimha, Bengaluru Saturday, May 9, 2026, 08:00 Hrs [IST] Pharmacy c ...

The Parliamentary Panel on Health and Family Welfare has recommended to the Ministry of Ayush to create a dedicated Ayush Infrastructure Fund with multi-year capital option for institutional ...

Indian hospitals note early referral to specialized care centers could spot hemophilia early before it becomes a medical emergency. In India and globally, hemophilia remains undiagnosed or ...

PCI announces extended timeline for approval process during AY 2026-27: Gireesh Babu, New Delhi Saturday, May 9, 2026, 08:00 ...

To support WHO member countries in their efforts to implement new policy recommendations for TB diagnostic testing, the World Health Organization (WHO) and the Stop TB Partnership have published the ...

Dr Reddy’s and Nestlé Health Science strengthens presence in diabetes & obesity nutrition space with Celevida GLP+ launch: Our Bureau, Bengaluru Friday, May 8, 2026, 13:30 Hrs ...

Procter & Gamble Health introduces Neurobion Nerve Pain Relief Cream for symptomatic relief from nerve-related pain: Our Bureau, Bengaluru Friday, May 8, 2026, 14:45 Hrs [IST] Neu ...

GSK to present 33 abstracts on latest respiratory research to advance patient care at ATS 2026: London, UK Friday, May 8, 2026, 11:00 Hrs [IST] GSK plc will present 33 abstracts, ...

Bayer announced positive topline results from the phase III REVEAL study, an investigator-initiated study by Brigham and Women’s Hospital that evaluated the investigational PET/CT radiotracer I 124 ...

Samsung Bioepis Co Ltd, a biopharmaceutical company committed to realizing healthcare that is accessible to everyone, has announced that the phase 1 study on SB27, a proposed biosimilar to Keytruda ...